Patents Assigned to VYMEDIC, LLC
-
Patent number: 12702677Abstract: The disclosure provides an oral antiviral supplement composition comprising a lysine, an ascorbic compound, a flavonoid glycoside, a threonine, and a pyridoxine. The disclosure also provides a method of reducing viral replication in a cell comprising treating a virus-infected cell with a composition of the disclosure. The disclosure further provides a method for the treatment and prophylaxis of a viral infection in a patient comprising administering a composition of the disclosure.Type: GrantFiled: October 18, 2023Date of Patent: August 11, 2026Assignee: Vymedic, LLCInventors: Kenneth E. Phillips, Cynthia A. Winning
-
Patent number: 11826377Abstract: The disclosure provides an oral antiviral supplement composition comprising a lysine, an ascorbic compound, a flavonoid glycoside, a threonine, and a pyridoxine. The disclosure also provides a method of reducing viral replication in a cell comprising treating a virus-infected cell with a composition of the disclosure. The disclosure further provides a method for the treatment and prophylaxis of a viral infection in a patient comprising administering a composition of the disclosure.Type: GrantFiled: November 17, 2021Date of Patent: November 28, 2023Assignee: Vymedic, LLCInventors: Kenneth E. Phillips, Cynthia A. Winning
-
Patent number: 11224606Abstract: The disclosure provides an oral antiviral supplement composition comprising a lysine, an ascorbic compound, a flavonoid glycoside, a threonine, and a pyridoxine. The disclosure also provides a method of reducing viral replication in a cell comprising treating a virus-infected cell with a composition of the disclosure. The disclosure further provides a method for the treatment and prophylaxis of a viral infection in a patient comprising administering a composition of the disclosure.Type: GrantFiled: September 25, 2019Date of Patent: January 18, 2022Assignee: Vymedic, LLCInventors: Kenneth E. Phillips, Cynthia A. Winning
-
Patent number: 10478447Abstract: The disclosure provides an oral antiviral supplement composition comprising a lysine, an ascorbic compound, a flavonoid glycoside, a threonine, and a pyridoxine. The disclosure also provides a method of reducing viral replication in a cell comprising treating a virus-infected cell with a composition of the disclosure. The disclosure further provides a method for the treatment and prophylaxis of a viral infection in a patient comprising administering a composition of the disclosure.Type: GrantFiled: January 29, 2018Date of Patent: November 19, 2019Assignee: Vymedic, LLCInventors: Kenneth E. Phillips, Cynthia A. Winning
-
Patent number: 9907809Abstract: The disclosure provides an oral antiviral supplement composition comprising a lysine, an ascorbic compound, a flavonoid glycoside, a threonine, and a pyridoxine. The disclosure also provides a method of reducing viral replication in a cell comprising treating a virus-infected cell with a composition of the disclosure. The disclosure further provides a method for the treatment and prophylaxis of a viral infection in a patient comprising administering a composition of the disclosure.Type: GrantFiled: April 8, 2015Date of Patent: March 6, 2018Assignee: Vymedic, LLCInventors: Kenneth E. Phillips, Cynthia A. Winning
-
Patent number: 9034834Abstract: The disclosure provides an oral antiviral supplement composition comprising a lysine, an ascorbic compound, a flavonoid glycoside, a threonine, and a pyridoxine. The disclosure also provides a method of reducing viral replication in a cell comprising treating a virus-infected cell with a composition of the disclosure. The disclosure further provides a method for the treatment and prophylaxis of a viral infection in a patient comprising administering a composition of the disclosure.Type: GrantFiled: October 30, 2009Date of Patent: May 19, 2015Assignee: Vymedic, LLCInventors: Kenneth E. Phillips, Cynthia A. Winning
-
Publication number: 20100113373Abstract: The disclosure provides an oral antiviral supplement composition comprising a lysine, an ascorbic compound, a flavonoid glycoside, a threonine, and a pyridoxine. The disclosure also provides a method of reducing viral replication in a cell comprising treating a virus-infected cell with a composition of the disclosure. The disclosure further provides a method for the treatment and prophylaxis of a viral infection in a patient comprising administering a composition of the disclosure.Type: ApplicationFiled: October 30, 2009Publication date: May 6, 2010Applicant: VYMEDIC, LLCInventors: Kenneth E. Phillips, Cynthia A. Winning
